JIXING Trademark

Trademark Overview


On Thursday, May 12, 2022, a trademark application was filed for JIXING with the United States Patent and Trademark Office. The USPTO has given the JIXING trademark a serial number of 97407895. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.. The JIXING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic pharmaceutical products; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; medicines for veterinary purposes, namely, veterinary diagnostic reagents, veterinary vaccines, Anti-infective products for veterinary use, and Veterinary preparations, namely, pain relief medication; Enzymes for veterinary purposes; biocides; disinfectant wipes; preparations to facilitate teething; diapers for pets; pharmaceutical candy, namely, medicated candies; medicines for human...

Scientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; drug testing services; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) services, namely, hosting software for use by others for use in database management, use as a spreadsheet, word processing; pharmaceutical drug research services; pharmaceutical drug development services
jixing

General Information


Serial Number97407895
Word MarkJIXING
Filing DateThursday, May 12, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized word "JIXING" in green with the design of a broken heart to the left in color with the left side of the heart being orange and the right side being green with a helix in between the two sides.
Goods and ServicesPharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic pharmaceutical products; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; medicines for veterinary purposes, namely, veterinary diagnostic reagents, veterinary vaccines, Anti-infective products for veterinary use, and Veterinary preparations, namely, pain relief medication; Enzymes for veterinary purposes; biocides; disinfectant wipes; preparations to facilitate teething; diapers for pets; pharmaceutical candy, namely, medicated candies; medicines for human purposes, namely, human vaccine preparations, Antibiotics for human use, anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; pharmaceutical preparations, namely, pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; chemico-pharmaceutical preparations, namely, chemico-pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; ointments for pharmaceutical purposes, namely, antibiotic, sunburn, anti-inflammatory ointments for pharmaceutical purposes; bronchodilating preparations; injectable pharmaceuticals, namely, injectable pharmaceuticals for treatment of anaphylactic reactions; tablets for pharmaceutical purposes, namely, medicinal preparations for the mouth to be applied in the form of tablets and compressed tablets; tincture of iodine; herbal tinctures for medical purposes; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesterolemia
Indication of Colors claimedThe color(s) orange and green is/are claimed as a feature of the mark.
Goods and ServicesScientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; drug testing services; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) services, namely, hosting software for use by others for use in database management, use as a spreadsheet, word processing; pharmaceutical drug research services; pharmaceutical drug development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJi Xing Pharmaceuticals (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 200040
CN

Party NameJi Xing Pharmaceuticals (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200040
CN

Trademark Events


Event DateEvent Description
Wednesday, May 18, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 16, 2022NEW APPLICATION ENTERED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 30, 2022ASSIGNED TO EXAMINER
Tuesday, May 31, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 31, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 30, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, November 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 8, 2023SUSPENSION INQUIRY WRITTEN
Thursday, June 8, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, June 8, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 30, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 22, 2024ASSIGNED TO LIE
Monday, January 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2024SUSPENSION LETTER WRITTEN
Monday, January 22, 2024LETTER OF SUSPENSION E-MAILED
Monday, January 22, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 2, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, August 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, August 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE